Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts)

Discovered in 1965, bone morphogenetic proteins (BMPs) are a group of cytokines from the transforming growth factor‐β (TGFβ) superfamily with significant roles in bone and cartilage formation. BMPs are used as powerful osteoinductive components of diverse tissue‐engineering products for the healing of bone. Several BMPs with different physiological roles have been identified in humans. The purpose of this review is to cover the biological function of the main members of BMP family, the latest research on BMPs signalling pathways and advances in the production of recombinant BMPs for tissue engineering purposes. Copyright © 2008 John Wiley & Sons, Ltd.

[1]  K. Miyazono,et al.  Characterization of a bone morphogenetic protein-responsive Smad-binding element. , 2000, Molecular biology of the cell.

[2]  A. Reddi.  Cartilage‐derived morphogenetic proteins and cartilage morphogenesis , 1998, Microscopy research and technique.

[3]  W. Sebald,et al.  Cooperativity of Binding Epitopes and Receptor Chains in the BMP/TGFß Superfamily , 2001, Biological chemistry.

[4]  D. Greenspan,et al.  Bone Morphogenetic Protein-1: The Type I Procollagen C-Proteinase , 1996, Science.

[5]  W. Sebald,et al.  Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution. , 1999, Journal of molecular biology.

[6]  Y. Verma,et al.  Mesenchymal stem cells: molecular targets for tissue engineering. , 2007, Stem cells and development.

[7]  A. Reddi,et al.  The application of bone morphogenetic proteins to dental tissue engineering , 2003, Nature Biotechnology.

[8]  J. Wozney,et al.  Biotinated bone morphogenetic protein-2: In vivo and in vitro activity. , 1999, Biotechnology and bioengineering.

[9]  Ken W. Y. Cho,et al.  Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. , 1997, Development.

[10]  J. Wozney,et al.  Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Perelman,et al.  Collagen‐targeted BMP3 fusion proteins arrayed on collagen matrices or porous ceramics impregnated with Type I collagen enhance osteogenesis in a rat cranial defect model , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  A. Fainsod,et al.  The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4 , 1997, Mechanisms of Development.

[13]  T. Kirsch,et al.  The Crystal Structure of the BMP-2: BMPR-IA Complex and the Generation of BMP-2 Antagonists , 2001, The Journal of bone and joint surgery. American volume.

[14]  K. Dechering,et al.  Gene Array Analysis of Bone Morphogenetic Protein Type I Receptor‐Induced Osteoblast Differentiation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Jae-Hyun Sung,et al.  BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression* , 2003, Journal of Biological Chemistry.

[16]  N. Kübler,et al.  Vergleich der osteogenen Potenz gentechnisch modifizierter BMP , 2005, Mund-, Kiefer- und Gesichtschirurgie.

[17]  Yingcui Li,et al.  Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[18]  N. Kübler,et al.  Evaluation der osteoinduktiven Potenz von gentechnisch modifizierten BMP-2-Varianten , 2004, Mund-, Kiefer- und Gesichtschirurgie.

[19]  K. Chihara,et al.  Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor β-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2* , 2004, Journal of Biological Chemistry.

[20]  R. Trembath,et al.  Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension , 2000, Nature Genetics.

[21]  J. Massagué,et al.  OAZ Uses Distinct DNA- and Protein-Binding Zinc Fingers in Separate BMP-Smad and Olf Signaling Pathways , 2000, Cell.

[22]  A. Aono,et al.  Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. , 1995, Biochemical and biophysical research communications.

[23]  X. Qi,et al.  Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Feldman,et al.  A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. , 2003, Bone.

[25]  K. Miyazono,et al.  Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells , 2004, The EMBO journal.

[26]  U. Rinas,et al.  Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli. , 2002, Journal of biotechnology.

[27]  A. Hoffmann,et al.  Transforming Growth Factor-β-activated Kinase-1 (TAK1), a MAP3K, Interacts with Smad Proteins and Interferes with Osteogenesis in Murine Mesenchymal Progenitors*[boxs] , 2005, Journal of Biological Chemistry.

[28]  Mallika Singh,et al.  An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis , 2003, Nature Biotechnology.

[29]  Phil G Knight,et al.  TGF-beta superfamily members and ovarian follicle development. , 2006, Reproduction.

[30]  Y. Henis,et al.  Initiation of Smad-Dependent and Smad-Independent Signaling via Distinct BMP-Receptor Complexes , 2003, The Journal of bone and joint surgery. American volume.

[31]  W. Sebald,et al.  Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.

[32]  Takamasa S. Yamamotoa,et al.  PII: S0925-4773(99)00290-7 , 2000 .

[33]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[34]  W. Sufan,et al.  Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. , 2000, Journal of biomedical materials research.

[35]  R. Kaufman,et al.  Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. , 1992, Growth factors.

[36]  T. Kirsch,et al.  BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II , 2000, The EMBO journal.

[37]  J. Woodgett,et al.  The stress-activated protein kinase pathways , 1999, Cellular and Molecular Life Sciences CMLS.

[38]  U. Strähle,et al.  Cleavage of the BMP-4 antagonist chordin by zebrafish tolloid. , 1997, Science.

[39]  Lorenz Meinel,et al.  Localized delivery of growth factors for bone repair. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  Mallika Singh,et al.  Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.

[41]  F. Luyten,et al.  Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. , 1994, Experimental cell research.

[42]  A. Reddi,et al.  Cartilage morphogenetic proteins: role in joint development, homoeostasis, and regeneration , 2003, Annals of the rheumatic diseases.

[43]  W. Vale,et al.  Inhibin Is an Antagonist of Bone Morphogenetic Protein Signaling* , 2003, The Journal of Biological Chemistry.

[44]  Yoshihisa Suzuki,et al.  Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. , 2003, Biochimica et biophysica acta.

[45]  S. Kuhara,et al.  Two closely‐related left‐right asymmetrically expressed genes, lefty‐1 and lefty‐2: their distinct expression domains, chromosomal linkage and direct neuralizing activity in Xenopus embryos , 1997, Genes to cells : devoted to molecular & cellular mechanisms.

[46]  Y. Mishina,et al.  BMP signaling and early embryonic patterning. , 2005, Cytokine & growth factor reviews.

[47]  J. Rodríguez-León,et al.  A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. , 2004, Developmental biology.

[48]  Yoshihisa Suzuki,et al.  Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. , 2004, Journal of biomedical materials research. Part A.

[49]  K. Miyazono,et al.  The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling , 2001, The Journal of cell biology.

[50]  P. G. Knight,et al.  FOCUS ON TGF-? SIGNALLING: TGF-B SUPERFAMILY MEMBERS AND OVARIAN FOLLICLE DEVELOPMENT , 2006 .

[51]  H. Seeherman,et al.  Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. , 2005, Cytokine & growth factor reviews.

[52]  P. Schnegelsberg,et al.  Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis. , 1992, The Journal of biological chemistry.

[53]  V. Rosen,et al.  Purification and characterization of other distinct bone-inducing factors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Szatkowski,et al.  Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery , 2004, Gene Therapy.

[55]  A. Banerjee,et al.  Expression and Purification of Biologically Active Rat Bone Morphogenetic Protein-4 produced as Inclusion Bodies in Recombinant Escherichia coli , 2005 .

[56]  K. Wenger,et al.  Loss of myostatin (GDF8) function increases osteogenic differentiation of bone marrow-derived mesenchymal stem cells but the osteogenic effect is ablated with unloading. , 2007, Bone.

[57]  Victor E. Velculescu,et al.  Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis , 2001, Nature Genetics.

[58]  N. Suzuki,et al.  Autoregulatory mechanism of Runx2 through the expression of transcription factors and bone matrix proteins in multipotential mesenchymal cell line, ROB-C26. , 2005, Journal of oral science.

[59]  J. Massagué.  Integration of Smad and MAPK pathways: a link and a linker revisited. , 2003, Genes & development.

[60]  Naoto Ueno,et al.  Action Range of BMP Is Defined by Its N-Terminal Basic Amino Acid Core , 2002, Current Biology.

[61]  B. Hogan,et al.  The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. , 1996, Genes & development.

[62]  T. Malinin,et al.  Human Bone Morphogenetic Protein (hBMP) 1 , 1983, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[63]  David J. Anderson,et al.  Late-emigrating neural crest cells in the roof plate are restricted to a sensory fate by GDF7. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Keene,et al.  The Prodomain of BMP-7 Targets the BMP-7 Complex to the Extracellular Matrix* , 2005, Journal of Biological Chemistry.

[65]  J. Zavadil,et al.  Integration of TGF‐β/Smad and Jagged1/Notch signalling in epithelial‐to‐mesenchymal transition , 2004 .

[66]  Yoshihisa Suzuki,et al.  Accelerated bone repair with the use of a synthetic BMP-2-derived peptide and bone-marrow stromal cells. , 2005, Journal of biomedical materials research. Part A.

[67]  V. Rosen,et al.  Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.

[68]  K. Miyazono,et al.  A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Ayse B. Celil,et al.  Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling , 2005, Journal of cellular biochemistry.

[70]  K. Miyazono,et al.  Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.

[71]  R. Rudolph,et al.  Biophysical Comparison of BMP-2, ProBMP-2, and the Free Pro-peptide Reveals Stabilization of the Pro-peptide by the Mature Growth Factor* , 2005, Journal of Biological Chemistry.

[72]  M. Goumans,et al.  Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells , 2004, The EMBO journal.

[73]  A. Reddi.  Cell biology and biochemistry of endochondral bone development. , 1981, Collagen and related research.

[74]  C. Ibáñez,et al.  Growth differentiation factor 11 signals through the transforming growth factor‐β receptor ALK5 to regionalize the anterior–posterior axis , 2006, EMBO reports.

[75]  J. Wozney,et al.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. , 2000, Journal of biomedical materials research.

[76]  F. Luyten,et al.  Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. , 2007, Arthritis and rheumatism.

[77]  S. Vukicevic,et al.  Bone morphogenetic proteins in development and homeostasis of kidney. , 2005, Cytokine & growth factor reviews.

[78]  R. Derynck,et al.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  W. Sebald,et al.  [Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants]. , 2005, Mund-, Kiefer- und Gesichtschirurgie : MKG.

[80]  N. Rudarakanchana,et al.  Serotonin Increases Susceptibility to Pulmonary Hypertension in BMPR2-Deficient Mice , 2006, Circulation research.

[81]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[82]  Jing Wang,et al.  BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[83]  K. Miyazono,et al.  Id: A Target of BMP Signaling , 2002, Science's STKE.

[84]  Hollinger,et al.  Sustained release emphasizing recombinant human bone morphogenetic protein-2. , 1998, Advanced drug delivery reviews.

[85]  J. Massagué,et al.  Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells , 1994, Molecular and Cellular Biology.

[86]  H. S. Azevedo,et al.  Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends , 2007, Journal of The Royal Society Interface.

[87]  Thomas A Einhorn,et al.  Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[88]  U. Lendahl,et al.  Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation , 2003, Development.

[89]  S. Vukicevic,et al.  Expression of bone morphogenetic proteins and cartilage‐derived morphogenetic proteins during osteophyte formation in humans , 2003, Journal of anatomy.

[90]  M. Matzuk,et al.  GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina , 2005, Science.

[91]  H. Schreuder,et al.  Crystal structure of recombinant human growth and differentiation factor 5: evidence for interaction of the type I and type II receptor-binding sites. , 2005, Biochemical and biophysical research communications.

[92]  D. Greenspan,et al.  GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells , 2005, Molecular and Cellular Biology.

[93]  J. Wozney,et al.  Delivery Systems for BMPs: Factors Contributing to Protein Retention at an Application Site , 2001, The Journal of bone and joint surgery. American volume.

[94]  Takeshi Imamura,et al.  Coordinate regulation of cell growth and differentiation by TGF-β superfamily and Runx proteins , 2004, Oncogene.

[95]  L. Nelles,et al.  SIP1, a Novel Zinc Finger/Homeodomain Repressor, Interacts with Smad Proteins and Binds to 5′-CACCT Sequences in Candidate Target Genes* , 1999, The Journal of Biological Chemistry.

[96]  G. Thomas,et al.  Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4. , 2004, Molecular biology of the cell.

[97]  Se-Jin Lee,et al.  Regulation of metanephric kidney development by growth/differentiation factor 11. , 2003, Developmental biology.

[98]  D. Norris,et al.  Cell fate decisions within the mouse organizer are governed by graded Nodal signals. , 2003, Genes & development.

[99]  W. Sebald,et al.  Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. , 1998, International journal of oral and maxillofacial surgery.

[100]  David J. Anderson,et al.  Neural Crest Stem Cells Undergo Cell-Intrinsic Developmental Changes in Sensitivity to Instructive Differentiation Signals , 2001, Neuron.

[101]  M. Urist,et al.  Solubilized and insolubilized bone morphogenetic protein. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Y. Yokota.  Id and development , 2001, Oncogene.

[103]  A. Reddi,et al.  Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[104]  R. Derynck,et al.  Smad-dependent and Smad-independent pathways in TGF-beta family signalling. , 2003, Nature.

[105]  C. Wright,et al.  Activin- and Nodal-related factors control antero–posterior patterning of the zebrafish embryo , 2000, Nature.

[106]  J. Blusztajn,et al.  Developmental pattern of expression of BMP receptors and Smads and activation of Smad1 and Smad5 by BMP9 in mouse basal forebrain , 2006, Brain Research.

[107]  W. Sebald,et al.  [The biological activity of E. coli-expressed BMP-4]. , 1998, Mund-, Kiefer- und Gesichtschirurgie : MKG.

[108]  H. H. Tillman.  A study of bone regeneration; report of a case of adenoma of the parathyroid gland with extensive bone changes. , 1956, Oral surgery, oral medicine, and oral pathology.

[109]  G. Balian,et al.  Growth and differentiation factor-5 (GDF-5) stimulates osteogenic differentiation and increases vascular endothelial growth factor (VEGF) levels in fat-derived stromal cells in vitro. , 2007, Bone.

[110]  F. Otsuka,et al.  The bone morphogenetic protein system in mammalian reproduction. , 2004, Endocrine reviews.

[111]  Philippe Soriano,et al.  In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis. , 2004, Genes & development.

[112]  R. Derynck,et al.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. , 2001, Genes & development.

[113]  R. Surabhi,et al.  TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway , 2003 .

[114]  A. Irie,et al.  Heparan sulfate is required for bone morphogenetic protein-7 signaling. , 2003, Biochemical and biophysical research communications.

[115]  V. Rosen,et al.  Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.

[116]  M. Oelgeschläger,et al.  Regulation of bone morphogenetic proteins in early embryonic development , 2004, Naturwissenschaften.

[117]  A. Reddi,et al.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[118]  H. Yoshikawa,et al.  The role of bone morphogenetic proteins in endochondral bone formation. , 2005, Cytokine & growth factor reviews.

[119]  T. Maniatis,et al.  Immune Activation of NF-κB and JNK Requires Drosophila TAK1* , 2003, Journal of Biological Chemistry.

[120]  K. Miyazono,et al.  BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. , 2005, Cytokine & growth factor reviews.

[121]  N. Faucheux,et al.  Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres , 2007, Journal of materials science. Materials in medicine.

[122]  W. Sebald,et al.  Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction , 2004, Biological chemistry.

[123]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[124]  R. Derynck,et al.  Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo , 1994, The Journal of cell biology.

[125]  D. L. Griffith,et al.  Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[126]  Yoshihisa Suzuki,et al.  Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alpha-tricalcium phosphate scaffold. , 2006, Journal of biomedical materials research. Part A.

[127]  Jeffrey L. Wrana,et al.  A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation , 1999, Nature.

[128]  K. Miyazono,et al.  Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. , 2003, Molecular biology of the cell.

[129]  C. Chung,et al.  Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2. , 2006, Journal of biomedical materials research. Part A.

[130]  K. Kangawa,et al.  Bone morphogenetic protein-3 family members and their biological functions. , 2004, Frontiers in bioscience : a journal and virtual library.

[131]  H. Shibuya,et al.  A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. , 1999, Developmental biology.

[132]  K. Miyazono,et al.  Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. , 2001, Journal of cell science.

[133]  V. Rosen,et al.  BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in Xenopus embryos. , 2005, Developmental biology.

[134]  J. Wozney,et al.  Dlx5 Specifically Regulates Runx2 Type II Expression by Binding to Homeodomain-response Elements in the Runx2 Distal Promoter* , 2005, Journal of Biological Chemistry.

[135]  Y. Qiao,et al.  [Soluble expression of recombinant human BMP6 in Escherichia coli and its purification and bioassay in vitro]. , 2008, Sheng wu gong cheng xue bao = Chinese journal of biotechnology.

[136]  K. Miyazono,et al.  Growth/differentiation factor-5 induces angiogenesis in vivo. , 1997, Experimental cell research.

[137]  M. Kretzschmar,et al.  Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 , 1997, Nature.

[138]  R. Reis,et al.  Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli , 2007, Biotechnology Letters.

[139]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[140]  R. Harland,et al.  The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. , 1998, Molecular cell.

[141]  K. Miyazono,et al.  RUNX transcription factors as key targets of TGF-β superfamily signaling , 2003 .

[142]  E. D. De Robertis,et al.  Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. , 2003, Genes & development.

[143]  K. Miyazono.  TGF-β signaling by Smad proteins , 2000 .

[144]  C. Chung,et al.  Osteopromotion with synthetic oligopeptide-coated bovine bone mineral in vivo. , 2007, Journal of periodontology.

[145]  Xueying Gu,et al.  GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development , 2004, Development.

[146]  J. Wozney,et al.  rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics , 1999, Annals of the New York Academy of Sciences.

[147]  C. Heldin,et al.  Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. , 2003, Molecular biology of the cell.

[148]  N. Ueno,et al.  Mesoderm induction by BMP-4 and -7 heterodimers. , 1997, Biochemical and biophysical research communications.

[149]  B. Riggs,et al.  Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. , 1998, The Journal of clinical investigation.

[150]  Markus Affolter,et al.  Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.

[151]  Franz E Weber,et al.  Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.

[152]  W. Sebald,et al.  [Evaluation of the osteoinductive potential of genetically modified BMP-2 variants]. , 2004, Mund-, Kiefer- und Gesichtschirurgie : MKG.

[153]  K. Miyazono,et al.  Stimulation of Smad1 Transcriptional Activity by Ras‐Extracellular Signal‐Regulated Kinase Pathway: A Possible Mechanism for Collagen‐Dependent Osteoblastic Differentiation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[154]  U. Rinas,et al.  Optimized procedure for renaturation of recombinant human bone morphogenetic protein‐2 at high protein concentration , 2004, Biotechnology and bioengineering.

[155]  Sanjay Kumar,et al.  Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction. , 2004, Biochimica et biophysica acta.

[156]  Michael D. Schneider,et al.  BMP10 is essential for maintaining cardiac growth during murine cardiogenesis , 2004, Development.

[157]  Y. Tabata,et al.  Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. , 2003, Biomaterials.

[158]  X. Cao,et al.  Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling* , 1999, The Journal of Biological Chemistry.

[159]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[160]  Dongsun Cao,et al.  Bone Morphogenetic Protein Signaling Modulates Myocardin Transactivation of Cardiac Genes , 2005, Circulation research.

[161]  Naoto Ueno,et al.  Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer , 2000, Nature.

[162]  Ariel J. Levine,et al.  GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos , 2005, Development.

[163]  J. Dodd,et al.  A Role for BMP Heterodimers in Roof Plate-Mediated Repulsion of Commissural Axons , 2003, Neuron.

[164]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[165]  U. Hellman,et al.  Proteins associated with type II bone morphogenetic protein receptor (BMPR‐II) and identified by two‐dimensional gel electrophoresis and mass spectrometry , 2004, Proteomics.

[166]  C. Kaps,et al.  Distinct roles of BMP receptors Type IA and IB in osteo‐/chondrogenic differentiation in mesenchymal progenitors (C3H10T1/2) , 2004, BioFactors.

[167]  A. Reddi.  BMPs: from bone morphogenetic proteins to body morphogenetic proteins. , 2005, Cytokine & growth factor reviews.

[168]  H. Oppermann,et al.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. , 1992, The Journal of biological chemistry.

[169]  Chad H. Koonce,et al.  BMP4 substitutes for loss of BMP7 during kidney development. , 2005, Developmental biology.

[170]  R. Harland,et al.  The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4 , 1996, Cell.

[171]  M. Šuša,et al.  Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. , 2004, The Journal of biological chemistry.